Surya Life Sciences Limited, a active public limited company, was established on 04 July 2005 in Navi Mumbai, Maharashtra, India. Engaging in aromatics & benzene derivatives within the manufacturing sector, it holds CIN: U24230MH2005PLC154467. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹6.10 Cr and a paid-up capital of ₹5.99 Cr.
It upholds a compliant status. Employing 64 professional, Its leadership includes Neha Yash Joshi (Director), Arun Durgaprasad Joshi (Director), Sandhya Arunbhai Joshi (Director). Past directors included Priti Arun Joshi. It holds ₹39.50 Cr open charges and ₹52.61 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at B-206, Radhamit Society,Plot No 33 , Sector 18,Nerul West, Navi Mumbai, Maharashtra, 400706.
U24230MH2005PLC154467
154467
04 July 2005
₹6.10 Cr
₹5.99 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Surya Life Sciences Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Neha Yash Joshi | Director | 16 Feb 2022 | Current |
| Arun Durgaprasad Joshi | Director | 04 Jul 2005 | Current |
| Sandhya Arunbhai Joshi | Director | 04 Jul 2005 | Current |
| Yash Arun Joshi | Director | 04 Jul 2005 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 18 Oct 2012 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Surya Life Sciences Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 19.76% increase. The company also saw a substantial improvement in profitability, with a 104.67% increase in profit. The company's net worth Soared by an impressive increase of 12.71%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Surya Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹395,000,000.00
₹526,053,446.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Nov 2023 | Others | ₹29.50 Cr | Open |
| 03 Nov 2023 | Others | ₹10.00 Cr | Open |
| 24 Mar 2023 | Axis Bank Limited | ₹2.00 Cr | Satisfied |
| 22 Oct 2020 | Axis Bank Limited | ₹1.98 M | Satisfied |
| 11 Jan 2019 | Axis Bank Limited | ₹0.73 M | Satisfied |
Explore comprehensive loan charge details -
Surya Life Sciences has a workforce of 64 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Surya Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Surya Life Sciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge registered on 24 Mar 2023 via Charge ID 100698238 with Axis Bank Limited was fully satisfied on 20 Nov 2025. was documented.
The activity A charge registered on 11 Jan 2019 via Charge ID 100235318 with Axis Bank Limited was fully satisfied on 17 Nov 2025. was completed.
The activity A charge registered on 22 Oct 2020 via Charge ID 100387337 with Axis Bank Limited was fully satisfied on 12 Nov 2025. was completed.
Progress on Surya Life Sciences Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.
The activity A charge registered on 27 Nov 2012 via Charge ID 10389896 with Axis Bank Limited was fully satisfied on 11 Jun 2025. was completed.
The activity A charge registered on 16 Oct 2012 via Charge ID 10383817 with Axis Bank Limited was fully satisfied on 11 Jun 2025. was completed.
The CIN of Surya Life Sciences Limited is U24230MH2005PLC154467.
Surya Life Sciences Limited is headquartered at B-206, Radhamit Society,Plot No 33 , Sector 18,Nerul West, Navi Mumbai, Maharashtra, 400706.
Surya Life Sciences Limited was incorporated on 04 July 2005.
The current directors of Surya Life Sciences Limited are
The primary industry of Surya Life Sciences Limited is Manufacturing.
Surya Life Sciences Limited is unlisted.
The authorized capital of Surya Life Sciences Limited is ₹6.10 Cr, and the paid-up capital is ₹5.99 Cr.
The compliance status of Surya Life Sciences Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX